Anzeige
Mehr »
Montag, 30.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DY2U | ISIN: US75990A2006 | Ticker-Symbol:
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
REMSLEEP HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
REMSLEEP HOLDINGS INC 5-Tage-Chart
ACCESS Newswire
155 Leser
Artikel bewerten:
(1)

RemSleep Holdings, Inc.: Deltawave CPAP Mask

Remsleep seeking Clinical Trials and Resellers for new arrival CPAP mask.

CLEARWATER, FL / ACCESS Newswire / June 30, 2025 / Remsleep Holdings, Inc. (OTC Pink:RMSL) Sleep, Naturally - The Deltawave Experience. Breath Like You're Sleeping. CPAP masks were meant to help us sleep. But for many, they're uncomfortable, noisy, and impossible to wear through the night. Meet the CPAP mask that breathes with you. "Deltawave brings patients back to comfort-and back to compliance." Where comfort meets science.

The Sleep Therapy Problem

> Up to 50% of CPAP users abandon therapy due to discomfort, pressure intolerance, or poor sleep quality.

The Deltawave Solution

"Deltawave restores a natural sleep-breathing rhythm like no other interface. It's restorative, pressure-free, and deeply comfortable."

How to Access Deltawave

  • Now available via 1-800-cpap

Why Deltawave Is a Game-Changer

  • 14 bpm rhythm for natural sleep breathing

  • Zero pressure resistance (inhalation & exhalation)

  • Minute ventilation, sigh reflex & I:E ratio fully supported

  • 100% comfort: no facial marks or tight headgear

  • Effective without humidification

  • Clears airways for duration of use more gently than any nasal decongestant

  • Works at only 5-5.8 cmH2O pressure

  • Ideal for full 8-hour wear without side effects

Clinical Benefits

  • Normalizes respiratory rhythm, eliminating apneas

  • Supports normal tidal volume, minute ventilation, and natural sighing

  • Removes expiratory workload-breathing powered by lung elasticity

  • Reduces cardiac strain by lowering mean airway pressure and restoring overall state of perfusion for duration of use

  • Compatible with long-term use in neuromuscular, cardiovascular, or pressure-sensitive patients

For Whom?

  • Sleep apnea sufferers sensitive to CPAP pressures

  • Veterans seeking non-invasive, low-resistance therapy improving overall state of perfusion

  • Hospitals and sleep labs ready to lead clinical innovation

  • Distributors seeking next-gen alternatives to commodity masks

Clinically Intelligent, Patient-Centered

  • No inspiratory or expiratory resistance-expiration powered solely by lung elasticity

  • Reduces cardiac workload by lowering mean airway pressures and improving overall state of perfusion

  • No humidification required, minimizing infection risk and system maintenance

  • No adverse effects to nasal mucosal membranes

  • Effective at low pressures: 5-5.8 cmH2O (summer) and 5-5.5 cmH2O (winter)

Made for Real People

  • No tight headgear required-comfortable through full 8-hour sleep cycles

  • Leaves no facial marks, supports indefinite wear

  • Instant, gentle nasal decongestion-clears airways better than medication for duration of use

  • No side effects reported during extended use

  • Targets root cause of most apnea: silent inflammation and blocked upper airways

> "Deltawave helps users sleep like they're not wearing a mask at all-yet without a single apneic event."

Clinical and Home Use Advantages

  • Requires no humidifier, minimizing infection risk and maintenance

  • Effective at low pressures: 5-5.8 cmH2O (summer), 5-5.5 cmH2O (winter)

  • Enhances cardiopulmonary rest, reducing cardiac load overnight

  • Designed for indefinite wear without adverse caustic effects

  • Immediately mitigates, or irradicates upper airway obstruction from inflammation, the root cause of most apnea

Ideal for Clinical Trials, VA Systems, and Distributors

The Deltawave represents a step-change in non-invasive ventilation, fusing technological elegance with patient-centered functionality. It is a strong candidate for:

  • VA System clinical trials or procurement

  • Research collaborations on low-pressure sleep therapy

  • Distributors seeking next-gen alternatives to standard CPAP

How does Deltawave mask compare to others on the market?

Great question-let's break it down! A CPAP mask that promotes normal breathing at 14 breaths per minute, eliminates negative inspiratory and expiratory pressure, and still prevents apneic events would be quite advanced. Here's how it stacks up against typical masks on the market:

Key Differentiators

Feature

Deltawave Mask

Typical CPAP Masks

Breath Synchronization

Matches natural rate (14 bpm)

Often fixed or auto-adjusting pressure, not breath-timed

Inspiratory Pressure

Eliminated (no negative draw)

Positive pressure may feel unnatural during inhalation

Expiratory Pressure

Eliminated (no resistance)

Many users struggle with exhalation against pressure

Apnea Prevention

Maintained

Maintained, but often at the cost of comfort

User Comfort

High-natural rhythm, no pressure strain

Varies-some find pressure uncomfortable or disruptive

Comfort & Compliance

  • Deltawave mask would likely feel more like natural breathing, which could dramatically improve comfort and reduce therapy dropout.

  • Standard masks (like full-face or nasal masks) often require acclimation due to pressure discomfort, especially during exhalation.

Technology Comparison

  • Deltawave concept resembles a hybrid of adaptive servo-ventilation (ASV) and expiratory pressure relief (EPR), but with even more refined control.

Who It's For

Patients

Clinicians

VA Systems

Distributors

Pressure-sensitive, CPAP-intolerant, neuromuscular patients

Sleep labs, respiratory teams

Trial-ready VA teams

CPAP/DME providers

Contact:

Tom Wood
Email: twood@remsleep.com
Phone: 912-590-2001

SOURCE: www.remsleep.com



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/deltawave-cpap-mask-1044195

© 2025 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.